Is serum vitamin d levels correlated with MRI findings in patients with relapsing remitting multiple sclerosis?

被引：0
|
作者：
Bunul, S. D. [1 ]
Efendi, H. [1 ]
Anik, Y. [2 ]
机构：
[1] Kocaeli Univ, Neurol, Kocaeli, Turkey
[2] Kocaeli Univ, Radiol, Kocaeli, Turkey
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2017年 / 381卷
关键词：
D O I：
10.1016/j.jns.2017.08.704
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
676
引用
收藏
页码：246 / 246
页数：1
相关论文
共 50 条
  • [41] Serum Uric Acid Level in Patients with Relapsing-Remitting Multiple Sclerosis
    Ashtari, Fereshteh
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 671 - 671
  • [42] Serum uric acid level in patients with relapsing-remitting multiple sclerosis
    Ashtari, Fereshteh
    Bahar, Mohammadali
    Aghaei, Maryam
    Zahed, Arash
    JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (05) : 676 - 678
  • [43] Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis
    Rosjo, Egil
    Myhr, Kjell-Morten
    Loken-Amsrud, Kristin I.
    Bakke, Soren J.
    Beiske, Antonie G.
    Bjerve, Kristian S.
    Hovdal, Harald
    Lilleas, Finn
    Midgard, Rune
    Pedersen, Tom
    Benth, Jurate Saltyte
    Torkildsen, Oivind
    Wergeland, Stig
    Michelsen, Annika E.
    Aukrust, Pal
    Ueland, Thor
    Holmoy, Trygve
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 280 : 21 - 28
  • [44] Subtyping relapsing–remitting multiple sclerosis using structural MRI
    Zhizheng Zhuo
    Yongmei Li
    Yunyun Duan
    Guanmei Cao
    Fenglian Zheng
    Jinli Ding
    Decai Tian
    Xinli Wang
    Jinhui Wang
    Xinghu Zhang
    Kuncheng Li
    Fuqing Zhou
    Muhua Huang
    Yuxin Li
    Haiqing Li
    Chun Zeng
    Ningnannan Zhang
    Jie Sun
    Chunshui Yu
    Xuemei Han
    Sven Haller
    Frederik Barkhof
    Fudong Shi
    Yaou Liu
    Journal of Neurology, 2021, 268 : 1808 - 1817
  • [45] Serum 25(OH) vitamin D level in Relapsing-Remitting Multiple Sclerosis and clinically isolated syndrome groups
    Kucuk, Ahmet
    Bir, Levent Sinan
    Tekin, Selma
    Demir, Suleyman
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2022, 43 (03) : 281 - 288
  • [46] Serum uric acid levels are decreased in patients with relapsing-remitting multiple sclerosis, in particular during relapses
    Tsakiri, Anna
    Tsiantoulas, Dimitris
    Frederiksen, Jette
    MULTIPLE SCLEROSIS, 2008, 14 : S289 - S289
  • [47] Association of serum neurofilament light levels and disease progression in patients with relapsing remitting multiple sclerosis treated with natalizumab
    Bridel, C.
    Leurs, C.
    Van Lierop, Z.
    Dekker, I.
    van Kempen, Z.
    Twaalfhoven, H.
    Moraal, B.
    Barkhof, F.
    Uitdehaag, B.
    Killestein, J.
    Teunissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 54 - 55
  • [48] Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β
    Balasa, Rodica
    Bajko, Zoltan
    Hutanu, Adina
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (07) : 885 - 890
  • [49] Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients
    Yuceyar, N
    Taskiran, D
    Sagduyu, A
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2001, 103 (04) : 206 - 211
  • [50] Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab
    Laursen, Julie Hejgaard
    Sondergaard, Helle Bach
    Sorensen, Per Soelberg
    Sellebjerg, Finn
    Oturai, Annette Bang
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 10 : 169 - 173
12345